Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity
Details for Australian Patent Application No. 2006218711 (hide)
International Classifications
Event Publications
4 October 2007 PCT application entered the National Phase
PCT publication WO2006/093993 Priority application(s): WO2006/093993
25 October 2007 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 13 Sep 2007
25 March 2010 Alteration of Name
The name of the applicant has been altered to University of Maryland, Baltimore
11 November 2010 Application Accepted
Published as AU-B-2006218711
10 March 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006218713-Foldable container including horizontally hinged sidwall sections
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser